HIMS
Hims Hers Health Inc
NYSE: HIMS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$26.33
-5.66% today
Updated 2026-04-29
Market cap
$6.08B
P/E ratio
51.63
P/S ratio
2.59x
EPS (TTM)
$0.51
Dividend yield
—
52W range
$14 – $70
Volume
38.8M
Hims Hers Health Inc (HIMS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-57.32M | $-74.87M | $-2.48M | $-34.41M | $-26.53M | $73.48M | $251.08M | $300.01M |
| Capital expenditures | $8000.00 | $1.79M | $4.23M | $5.01M | $7.25M | $26.49M | $52.75M | $226.04M |
| Depreciation | $260000.00 | $260000.00 | $1.06M | $4.08M | $7.47M | $9.52M | $17.09M | — |
| Stock-based comp | $7.32M | $8.03M | $5.83M | $67.21M | $42.82M | $66.08M | $92.32M | $135.24M |
| Free cash flow | $-57.33M | $-76.65M | $-6.71M | $-39.42M | $-33.78M | $46.99M | $198.33M | $73.96M |
| Investing cash flow | $-8000.00 | $-39.30M | $-39.70M | $-156.27M | $34.70M | $-12.11M | $-19.05M | — |
| Financing cash flow | $78.15M | $95.32M | $47.74M | $235.04M | $-33.13M | $-11.47M | $-107.84M | — |
| Dividends paid | — | — | $1.74M | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-452074.00 | $44.29M | — | — | — | — |